Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical implications of neuraxial anesthesia in the parturient with scoliosis.

Anesthesia and analgesia·2009

Same author

Bipolar spectrum disorder: a pilot study.

Psychopathology·2004

Same author

Antidepressant treatment in bipolar versus unipolar depression.

The American journal of psychiatry·2004

Same author

Oxcarbazepine treatment of refractory bipolar disorder: a retrospective chart review.

Bipolar disorders·2002

Same author

"Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2002

Search research articles

Related Experiment Video

Updated: May 8, 2026

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Published on: July 26, 2024

Excipient choices for special populations.

Karen M Nagel-Edwards¹, James Y Ko

¹Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois.

International Journal of Pharmaceutical Compounding

|August 24, 2013

Summary

This summary is machine-generated.

Compounding pharmacists must carefully select special excipients for patients with allergies or special diets. Identifying and eliminating problematic ingredients in manufactured drugs is crucial for patient safety and requires pharmacist expertise.

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Experiment Videos

Last Updated: May 8, 2026

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models

Published on: July 26, 2024

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Area of Science:

Pharmaceutical Sciences
Clinical Pharmacy

Background:

Patients with allergies, intolerances, or special dietary needs require specialized pharmaceutical formulations.
Pharmaceuticals may contain undeclared excipients (e.g., gluten, soy, dyes) that can trigger adverse reactions.
Unlike food products, manufactured drugs are not always required to list all ingredients, posing a risk to sensitive patients.

Purpose of the Study:

To highlight the importance of special excipients in pharmaceutical compounding.
To emphasize the challenges and necessity of identifying and excluding specific excipients for patient safety.

Main Methods:

Review of current practices in pharmaceutical compounding for patients with dietary restrictions.
Analysis of regulatory differences between food labeling and pharmaceutical ingredient disclosure.
Case considerations for pharmacists managing complex patient allergies.

Main Results:

Compounding pharmacists play a vital role in customizing medications by removing specific excipients.
Accurate identification of patient allergies and intolerances is critical for successful compounding.
The demand for specialized excipient formulations is expected to persist.

Conclusions:

The use of special excipients in compounding is essential for patient safety and adherence.
Pharmacists require enhanced knowledge and creative problem-solving skills to address diverse patient needs.
Continued innovation in pharmaceutical compounding is necessary to meet the evolving requirements of patients with sensitivities.